chr9-93645671-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_005392.4(PHF2):c.342G>A(p.Thr114=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0183 in 1,611,392 control chromosomes in the GnomAD database, including 345 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.021 ( 44 hom., cov: 34)
Exomes 𝑓: 0.018 ( 301 hom. )
Consequence
PHF2
NM_005392.4 synonymous
NM_005392.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.63
Genes affected
PHF2 (HGNC:8920): (PHD finger protein 2) This gene encodes a protein which contains a zinc finger-like PHD (plant homeodomain) finger, distinct from other classes of zinc finger motifs, and a hydrophobic and highly conserved domain. The PHD finger shows the typical Cys4-His-Cys3 arrangement. PHD finger genes are thought to belong to a diverse group of transcriptional regulators possibly affecting eukaryotic gene expression by influencing chromatin structure. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 9-93645671-G-A is Benign according to our data. Variant chr9-93645671-G-A is described in ClinVar as [Benign]. Clinvar id is 3038246.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-4.63 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.021 (3199/152342) while in subpopulation AFR AF= 0.0207 (860/41566). AF 95% confidence interval is 0.0195. There are 44 homozygotes in gnomad4. There are 1669 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3199 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHF2 | NM_005392.4 | c.342G>A | p.Thr114= | synonymous_variant | 4/22 | ENST00000359246.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHF2 | ENST00000359246.9 | c.342G>A | p.Thr114= | synonymous_variant | 4/22 | 1 | NM_005392.4 | P1 | |
PHF2 | ENST00000610682.1 | c.239+9206G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0210 AC: 3197AN: 152224Hom.: 44 Cov.: 34
GnomAD3 genomes
AF:
AC:
3197
AN:
152224
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0188 AC: 4706AN: 249840Hom.: 68 AF XY: 0.0192 AC XY: 2596AN XY: 135042
GnomAD3 exomes
AF:
AC:
4706
AN:
249840
Hom.:
AF XY:
AC XY:
2596
AN XY:
135042
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0180 AC: 26284AN: 1459050Hom.: 301 Cov.: 32 AF XY: 0.0182 AC XY: 13188AN XY: 725638
GnomAD4 exome
AF:
AC:
26284
AN:
1459050
Hom.:
Cov.:
32
AF XY:
AC XY:
13188
AN XY:
725638
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0210 AC: 3199AN: 152342Hom.: 44 Cov.: 34 AF XY: 0.0224 AC XY: 1669AN XY: 74484
GnomAD4 genome
AF:
AC:
3199
AN:
152342
Hom.:
Cov.:
34
AF XY:
AC XY:
1669
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
66
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PHF2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at